LSTA
NASDAQ
$3.53
Lisata Therapeutics Inc (LSTA)
Lisata Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on developing and commercializing cellular therapies to reverse disease and/or promote regeneration of damaged tissue. The company is headquartered in Basking Ridge, New Jersey.
Sector:
Healthcare
Industry:
Biotechnology
Target: $4 (+13.48%)
Market Cap
$34M
Free Cash Flow Yield
-39.91%
Price Chart
Valuation
Market Cap$34M
Forward P/E2.71
PEG118.40
P/S200.88
P/B3.09
Profitability
Total Revenue (TTM)$170K
Gross Profit (TTM)$170K
EBITDA-$17M
Operating Margin-10179%
EPS-$1.85
Financial Health
Free Cash Flow Yield-39.91%
Growth & Risk
EPS 5Y CAGR-14.27%
Revenue 5Y CAGR+1.86%
FCF 5Y CAGR+1.62%
Sharpe Ratio0.73